Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bitran

Showing results (131-140 of 197) with videos related to

Pageof 20
Sort By:
Clinical Genitourinary Cancer|October 31, 2013
Role of sorafenib in overcoming resistance of chemotherapy-failure castration-resistant prostate cancerAndrew Meyer, Peter Cygan, Kathy Tolzien, et al.
Cancer Treatment Reports|March 1, 1987
Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinomaR H Jacobs, J D Bitran, M Deutsch, et al.
Blood|January 1, 1978
Central nervous system involvement in patients with histiocytic lymphoma, diffuse typeD L Sweet, H M Golomb, J E Ultmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Concomitant chemoradiotherapy for non-small cell lung cancerE E Vokes, D J Haraf, P C Hoffman, et al.
Chest|March 1, 1978
Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapyJ D Bitran, T R DeMeester, K Rezai-Zadeh, et al.
Chest|July 1, 1989
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 studyE E Vokes, J D Bitran, P C Hoffman, et al.
Cancer Treatment Reports|September 1, 1981
Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot studyJ Ashenhurst, J D Bitran, E Robin, et al.
Urology|July 21, 2009
Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trialChadi Nabhan, Timothy M Lestingi, Angel Galvez, et al.
Cancer|February 1, 1983
Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyJ D Bitran, R K Desser, C M Shapiro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 3, 1998
Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxietyS S Smith, Q H Gong, X Li, et al.
Pageof 20

Showing results (131-140 of 197) with videos related to

Sort By:
Pageof 20
Clinical Genitourinary Cancer|October 31, 2013
Role of sorafenib in overcoming resistance of chemotherapy-failure castration-resistant prostate cancerAndrew Meyer, Peter Cygan, Kathy Tolzien, et al.
Cancer Treatment Reports|March 1, 1987
Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinomaR H Jacobs, J D Bitran, M Deutsch, et al.
Blood|January 1, 1978
Central nervous system involvement in patients with histiocytic lymphoma, diffuse typeD L Sweet, H M Golomb, J E Ultmann, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Concomitant chemoradiotherapy for non-small cell lung cancerE E Vokes, D J Haraf, P C Hoffman, et al.
Chest|March 1, 1978
Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapyJ D Bitran, T R DeMeester, K Rezai-Zadeh, et al.
Chest|July 1, 1989
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 studyE E Vokes, J D Bitran, P C Hoffman, et al.
Cancer Treatment Reports|September 1, 1981
Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot studyJ Ashenhurst, J D Bitran, E Robin, et al.
Urology|July 21, 2009
Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trialChadi Nabhan, Timothy M Lestingi, Angel Galvez, et al.
Cancer|February 1, 1983
Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapyJ D Bitran, R K Desser, C M Shapiro, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 3, 1998
Withdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxietyS S Smith, Q H Gong, X Li, et al.
Pageof 20